OR4A11P

Across TCGA pan-cancer cohorts, OR4A11P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated OR4A11P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR4A11P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4A11P expression acts as an unfavorable survival marker.

MESO, KIRC, and PAAD are the cancer types where OR4A11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	III,IV	0.043	0.415	<.001	54	view →
KIRC	DFS	Tertile	IV	0.114	0.640	.002	54	view →
PAAD	OS	Tertile	II,III,IV	0.241	0.561	.001	36	view →
SKCM	OS	Tertile	IV	0.243	0.666	.003	33	view →
BLCA	OS	Tertile	IV	0.183	0.598	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

OR4A11P–MESO (DFS)

Open the MESO breakdown →